<p><strong>ACM Research, Inc.</strong>（纳斯达克代码：ACMR）的股价在过去 30 天内大幅下跌了 28%，回吐了近期的许多涨幅。不过，糟糕的一个月并没有完全毁掉过去一年，股价上涨了 63%，即使在牛市中也表现出色。</p>
<p>即使在如此大幅的价格下跌之后，你仍然可以对 ACM Research 的市盈率 16.6 倍感到无所谓，因为美国的市盈率中位数也接近 18 倍。不过，简单忽视市盈率而不加解释并不明智，因为投资者可能会忽略一个明显的机会或一个代价高昂的错误。</p>
<p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
<p>最近一段时间对 ACM Research 来说是有利的，因为其收益增长速度超过了大多数其他公司。许多人可能预计强劲的收益表现会减弱，这使得市盈率未能上升。如果不是这样，那么现有股东有理由对股价未来的走势感到乐观。</p>
<p>查看我们对 ACM Research 的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/380776488-pe-multiple-vs-industry-1-dark-2/1763972622247?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/380776488-pe-multiple-vs-industry-1-dark-2/1763972622247"/></p>
<p>纳斯达克 GM:ACMR 市盈率与行业比较 2025 年 11 月 24 日</p>
<p>想要了解分析师对公司的完整估计吗？那么我们 <strong>免费的</strong>ACM Research 报告将帮助你揭示未来的趋势。</p>
<h2>增长是否与市盈率匹配？</h2>
<p>ACM Research 的市盈率对于一家仅预期实现适度增长的公司来说是典型的，重要的是，它的表现与市场保持一致。</p>
<p>如果我们回顾过去一年的收益增长，公司实现了 26% 的显著增长。最近三年期间，EPS 也整体上升了 148%，得益于其短期表现。因此，可以公平地说，最近的收益增长对公司来说是非常出色的。</p>
<p>展望未来，覆盖该公司的九位分析师的估计表明，未来三年每年的收益应增长 16%。这将显著高于更广泛市场预期的每年 11% 的增长。</p>
<p>考虑到这一点，令人好奇的是，ACM Research 的市盈率与大多数其他公司相当。显然，一些股东对预测持怀疑态度，并接受了较低的出售价格。</p>
<h2>ACM Research 市盈率的底线</h2>
<p>随着股价下跌，ACM Research 的市盈率现在看起来相当普通。通常，我们的偏好是将市盈率的使用限制在确定市场对公司整体健康状况的看法上。</p>
<p>我们已经确定，ACM Research 目前的市盈率低于预期，因为其预测增长高于更广泛的市场。当我们看到强劲的收益前景与快于市场的增长时，我们假设潜在风险可能是对市盈率施加压力的原因。至少价格下跌的风险看起来是被抑制的，但投资者似乎认为未来的收益可能会出现一些波动。</p>
<p>许多潜在风险可能存在于公司的资产负债表中。你可以通过我们 <strong>免费的</strong>ACM Research 资产负债表分析进行六项简单检查来评估许多主要风险。</p>
<p><strong>如果你对市盈率感兴趣</strong>，你可能希望查看这份 <strong>免费的</strong> 其他强劲收益增长和低市盈率公司的集合。</p>

ACMR

<p>ACM Research, Inc.（纳斯达克代码：ACMR）在过去 30 天内股价下跌了 28%，尽管过去一年上涨了 63%。其市盈率为 16.6 倍，接近美国中位数的 18 倍，暗示着适度的增长预期。公司的收益增长速度超过大多数公司，去年增长了 26%，三年内增长了 148%。分析师预测年均增长为 16%，高于市场的 11%。尽管收益前景强劲，但仍存在怀疑情绪，影响了市盈率</p>

<p>The <strong>ACM Research, Inc.</strong> (NASDAQ:ACMR) share price has softened a substantial 28% over the previous 30 days, handing back much of the gains the stock has made lately. Still, a bad month hasn't completely ruined the past year with the stock gaining 63%, which is great even in a bull market.</p>
<div class="lb-trans"><p><strong>ACM Research, Inc.</strong>（纳斯达克代码：ACMR）的股价在过去 30 天内大幅下跌了 28%，回吐了近期的许多涨幅。不过，糟糕的一个月并没有完全毁掉过去一年，股价上涨了 63%，即使在牛市中也表现出色。</p>
</div><p>Even after such a large drop in price, you could still be forgiven for feeling indifferent about ACM Research's P/E ratio of 16.6x, since the median price-to-earnings (or &#34;P/E&#34;) ratio in the United States is also close to 18x. Although, it's not wise to simply ignore the P/E without explanation as investors may be disregarding a distinct opportunity or a costly mistake.</p>
<div class="lb-trans"><p>即使在如此大幅的价格下跌之后，你仍然可以对 ACM Research 的市盈率 16.6 倍感到无所谓，因为美国的市盈率中位数也接近 18 倍。不过，简单忽视市盈率而不加解释并不明智，因为投资者可能会忽略一个明显的机会或一个代价高昂的错误。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
</div><p>Recent times have been advantageous for ACM Research as its earnings have been rising faster than most other companies. It might be that many expect the strong earnings performance to wane, which has kept the P/E from rising. If not, then existing shareholders have reason to be feeling optimistic about the future direction of the share price.</p>
<div class="lb-trans"><p>最近一段时间对 ACM Research 来说是有利的，因为其收益增长速度超过了大多数其他公司。许多人可能预计强劲的收益表现会减弱，这使得市盈率未能上升。如果不是这样，那么现有股东有理由对股价未来的走势感到乐观。</p>
</div><p>See our latest analysis for ACM Research</p>
<div class="lb-trans"><p>查看我们对 ACM Research 的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/380776488-pe-multiple-vs-industry-1-dark-2/1763972622247" alt="" original-src="https://images.simplywall.st/asset/chart/380776488-pe-multiple-vs-industry-1-dark-2/1763972622247"/></p>
<p>NasdaqGM:ACMR Price to Earnings Ratio vs Industry November 24th 2025</p>
<div class="lb-trans"><p>纳斯达克 GM:ACMR 市盈率与行业比较 2025 年 11 月 24 日</p>
</div><p>Want the full picture on analyst estimates for the company? Then our <strong>free</strong> report on ACM Research will help you uncover what's on the horizon.</p>
<div class="lb-trans"><p>想要了解分析师对公司的完整估计吗？那么我们 <strong>免费的</strong>ACM Research 报告将帮助你揭示未来的趋势。</p>
</div><h2>Does Growth Match The P/E?</h2>
<div class="lb-trans"><h2>增长是否与市盈率匹配？</h2>
</div><p>ACM Research's P/E ratio would be typical for a company that's only expected to deliver moderate growth, and importantly, perform in line with the market.</p>
<div class="lb-trans"><p>ACM Research 的市盈率对于一家仅预期实现适度增长的公司来说是典型的，重要的是，它的表现与市场保持一致。</p>
</div><p>If we review the last year of earnings growth, the company posted a terrific increase of 26%. The latest three year period has also seen an excellent 148% overall rise in EPS, aided by its short-term performance. Therefore, it's fair to say the earnings growth recently has been superb for the company.</p>
<div class="lb-trans"><p>如果我们回顾过去一年的收益增长，公司实现了 26% 的显著增长。最近三年期间，EPS 也整体上升了 148%，得益于其短期表现。因此，可以公平地说，最近的收益增长对公司来说是非常出色的。</p>
</div><p>Shifting to the future, estimates from the nine analysts covering the company suggest earnings should grow by 16% each year over the next three years. That's shaping up to be materially higher than the 11% per year growth forecast for the broader market.</p>
<div class="lb-trans"><p>展望未来，覆盖该公司的九位分析师的估计表明，未来三年每年的收益应增长 16%。这将显著高于更广泛市场预期的每年 11% 的增长。</p>
</div><p>In light of this, it's curious that ACM Research's P/E sits in line with the majority of other companies. Apparently some shareholders are skeptical of the forecasts and have been accepting lower selling prices.</p>
<div class="lb-trans"><p>考虑到这一点，令人好奇的是，ACM Research 的市盈率与大多数其他公司相当。显然，一些股东对预测持怀疑态度，并接受了较低的出售价格。</p>
</div><h2>The Bottom Line On ACM Research's P/E</h2>
<div class="lb-trans"><h2>ACM Research 市盈率的底线</h2>
</div><p>With its share price falling into a hole, the P/E for ACM Research looks quite average now. Generally, our preference is to limit the use of the price-to-earnings ratio to establishing what the market thinks about the overall health of a company.</p>
<div class="lb-trans"><p>随着股价下跌，ACM Research 的市盈率现在看起来相当普通。通常，我们的偏好是将市盈率的使用限制在确定市场对公司整体健康状况的看法上。</p>
</div><p>We've established that ACM Research currently trades on a lower than expected P/E since its forecast growth is higher than the wider market. When we see a strong earnings outlook with faster-than-market growth, we assume potential risks are what might be placing pressure on the P/E ratio. At least the risk of a price drop looks to be subdued, but investors seem to think future earnings could see some volatility.</p>
<div class="lb-trans"><p>我们已经确定，ACM Research 目前的市盈率低于预期，因为其预测增长高于更广泛的市场。当我们看到强劲的收益前景与快于市场的增长时，我们假设潜在风险可能是对市盈率施加压力的原因。至少价格下跌的风险看起来是被抑制的，但投资者似乎认为未来的收益可能会出现一些波动。</p>
</div><p>A lot of potential risks can sit within a company's balance sheet. You can assess many of the main risks through our <strong>free</strong> balance sheet analysis for ACM Research with six simple checks.</p>
<div class="lb-trans"><p>许多潜在风险可能存在于公司的资产负债表中。你可以通过我们 <strong>免费的</strong>ACM Research 资产负债表分析进行六项简单检查来评估许多主要风险。</p>
</div><p><strong>If P/E ratios interest you</strong>, you may wish to see this <strong>free</strong> collection of other companies with strong earnings growth and low P/E ratios.</p>
<div class="lb-trans"><p><strong>如果你对市盈率感兴趣</strong>，你可能希望查看这份 <strong>免费的</strong> 其他强劲收益增长和低市盈率公司的集合。</p>
</div>

ACM Research, Inc. (NASDAQ:ACMR) 已下跌 28%，但其风险可能比表面上看起来更大